These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10658478)

  • 41. Myeloablative radiochemotherapy followed by autologous peripheral blood stem cell transplantation as first-line therapy in peripheral T-cell lymphomas: first results of a prospective multicenter study.
    Reimer P; Schertlin T; Rüdiger T; Geissinger E; Roth S; Kunzmann V; Weissinger F; Nerl C; Schmitz N; Müller-Hermelink HK; Wilhelm M
    Hematol J; 2004; 5(4):304-11. PubMed ID: 15297846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [22-year-old man with T-cell-lymphoma and new skin lesions].
    Kampfenkel T; Schroers R; Kreuter A
    Dtsch Med Wochenschr; 2012 Mar; 137(9):429-30. PubMed ID: 22354798
    [No Abstract]   [Full Text] [Related]  

  • 43. Posttransplant primary cutaneous Ki-1 (CD30)+/CD56+ anaplastic large cell lymphoma.
    Kim HK; Jin SY; Lee NS; Won JH; Park HS; Yang WI
    Arch Pathol Lab Med; 2004 Aug; 128(8):e96-9. PubMed ID: 15270625
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.
    Kitahara H; Maruyama D; Maeshima AM; Makita S; Miyamoto KI; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Tajima K; Terauchi T; Kurihara H; Taniguchi H; Komatsu N; Tobinai K
    Ann Hematol; 2017 Mar; 96(3):411-420. PubMed ID: 27928587
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Trial of front-line intensive chemotherapy followed by peripheral blood stem cell transplantation in high-intermediate and high risk non-Hodgkin's lymphoma patients].
    Motomura S; Hashimoto C; Kodama F; Maruta A; Sakai R; Fujita H; Tomita N; Fujisawa S; Harano H; Koharazawa H; Fujimaki K; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 May; 46(5):350-7. PubMed ID: 16444968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Successful autologous bone marrow transplant for relapsed Ki-1 lymphoma.
    Takamura M; Mugishima H; Nagata T; Shichino H; Shimada T; Suzuki T; Chin M; Harada K; Fujimoto Z
    Acta Paediatr Jpn; 1995 Aug; 37(4):541-4. PubMed ID: 7572163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recurrence with histological transformation 40 days after autologous peripheral blood stem cell transplantation (APBSCT) for cutaneous CD30-negative large T cell lymphoma.
    Nishio M; Sawada K; Koizumi K; Tarumi T; Takano H; Endo T; Takashima H; Hashimoto H; Haseyama Y; Kobayashi H; Koike T
    Bone Marrow Transplant; 1998 Dec; 22(12):1211-4. PubMed ID: 9894726
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.
    Derenzini E; Casadei B; Broccoli A; Gandolfi L; Pellegrini C; Zinzani PL
    Br J Haematol; 2014 Aug; 166(4):625-8. PubMed ID: 24750128
    [No Abstract]   [Full Text] [Related]  

  • 49. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
    Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
    Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High-dose chemotherapy and APSCT as a potential cure for relapsing hemolysing AILD.
    Lindahl J; Kimby E; Björkstrand B; Christensson B; Hellström-Lindberg E
    Leuk Res; 2001 Mar; 25(3):267-70. PubMed ID: 11226525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcomatoid variant of anaplastic large cell lymphoma mimicking a primary breast cancer: a challenging diagnosis.
    Pereira EM; Maeda SA; Reis-Filho JS
    Arch Pathol Lab Med; 2002 Jun; 126(6):723-6. PubMed ID: 12033965
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fine needle aspiration cytology of ALK1(-), CD30+ anaplastic large cell lymphoma post renal transplantation: a case report and literature review.
    Balachandran I; Walker JW; Broman J
    Diagn Cytopathol; 2010 Mar; 38(3):213-6. PubMed ID: 19774614
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anaplastic large cell Ki-1 lymphoma arising in bone.
    Edwards MS; Fairbank J; Midgely P
    Eur Spine J; 1993 Dec; 2(4):239-41. PubMed ID: 20058412
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [High-dose therapy and peripheral blood stem cell transplantation for patients with aggressive non-Hodgkin's lymphoma remaining in initial remission: results of a feasibility study].
    Kitajima H; Nasu K; Tsudo M; Fujimoto M; Hayashi K; Ohno H; Konaka Y; Katsurada T; Arima N; Doi S; Moriguchi T; Fukuhara S
    Rinsho Ketsueki; 2001 Mar; 42(3):191-8. PubMed ID: 11345781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful treatment of disseminated nasal T-cell lymphoma using high-dose chemotherapy and autologus peripheral blood stem cell transplantation: a case report.
    Kouzaki H; Kitanishi T; Kitano H; Suzuki M
    Auris Nasus Larynx; 2004 Mar; 31(1):79-83. PubMed ID: 15041059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical outcomes of post-remission therapy using (90)yttrium ibritumomab tiuxetan (Zevalin®) for high-risk patients with diffuse large B-cell lymphoma.
    Han EJ; Lee SE; Kim SH; Sohn HS; Jung SE; Park G; Choi BO; Lee SN; Yang SW; Han K; Cho SG
    Ann Hematol; 2011 Sep; 90(9):1075-82. PubMed ID: 21336624
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anaplastic large cell lymphoma, ALK-positive.
    Ferreri AJ; Govi S; Pileri SA; Savage KJ
    Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
    d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
    J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study.
    Colombat P; Cornillet P; Deconinck E; Tourani JM; Gardembas M; Delain M; Abgrall JF; Kootz C; Milpied N
    Bone Marrow Transplant; 2000 Nov; 26(9):971-7. PubMed ID: 11100276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
    J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.